Select Publications

Book Chapters

Beretov J; Wasinger V; Graham P; Millar E; Kearsley J; Li Y, 2014, 'Proteomic techniques to detect urinary biomarkers in breast cancer', in Makowski G (ed.), Advances in Clinical Chemistry, Elsevier, pp. 123 - 167, http://www.sciencedirect.com/science/bookseries/00652423/63/supp/C

You J; Cozzi PJ; Fitzgerald A; Walsh B; Russell PJ; Willcox M; Graham P; Li Y, 2013, 'Tear as a source of protein biomarkers for human disease diagnosis and prognosis', in Makowski G (ed.), Tear as a source of protein biomarkers for human disease diagnosis and prognosis

You J; Cozzi PJ; Fitzgerald A; Walsh B; Russell ; Willcox MD; Li Y, 2012, 'Prostate Cancer Biomarkers and the Emerging Proteomic Techniques Used in Biomarker Research', in Watanabe HS (ed.), Horizons in Cancer Research Vol 47, edn. First, Nova Science Publishers Inc, New York, pp. 1 - 36, https://www.novapublishers.com/catalog/product_info.php?products_id=27295

Hao J; Madigan MC; Cozzi PJ; Kearsley J; Li Y; Hao J, 2011, 'Angiogenesis, Lymphangiogenesis and Vasculogenic Mimicry in Human Prostate Cancer Therapy', in Berhardt LV (ed.), Advances in Medicine and Biology, edn. Volume 38, Nova Science Publishers, Inc., New York, USA, pp. 49 - 90, https://www.novapublishers.com/catalog/product_info.php?products_id=32769

Xiao W; Graham PH; Power C; Li Y, 2010, 'Biomarkers for radiosensitivity and radiosensitivity targets in prostate cancer', in Nguyen SD (ed.), Tumour Suppressors, Nova Science Publishers, USA, pp. 189 - 228

Allen BJ; Li Y; Rizvi SM; Russell PJ, 2003, 'Targeted Alpha Therapy of Prostate Cancer', in Russell PJ (ed.), Prostrate Cancer Methods and Protocols, Humana Press, Totowa, new Jersey, pp. 333 - 357

Li Y; Li L; Krilis S, 1997, 'Growth factors modulating human mast cell growth and function', in Seminars in Clinical Immunology, edn. Original, Edizioni Grafiche Mazzucchelli S.B.L., Italy, pp. 17 - 24

Journal articles

Han M; Pang B; Zhou C; Li X; Wang Q; Jiang J; Li Y, 2022, 'Liquid biopsy of extracellular vesicle biomarkers for prostate cancer personalized treatment decision', Extracellular Vesicles and Circulating Nucleic Acids, http://dx.doi.org/10.20517/evcna.2021.20

Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y, 2021, 'THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer', Advanced Science, vol. 8, pp. 2102658 - 2102658, http://dx.doi.org/10.1002/advs.202102658

Li J; Gao N; Gao Z; Liu W; Pang B; Dong X; Li Y; Fan T, 2021, 'The Emerging Role of Exosomes in Cancer Chemoresistance', Frontiers in Cell and Developmental Biology, vol. 9, pp. 737962, http://dx.doi.org/10.3389/fcell.2021.737962

Dong H; Xie C; Jiang Y; Li K; Lin Y; Pang X; Xiong X; Zheng J; Ke X; Chen Y; Li Y; Zhang H, 2021, 'Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration', Frontiers in Cell and Developmental Biology, vol. 9, http://dx.doi.org/10.3389/fcell.2021.703537

Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y, 2021, 'Activation of the eIF2 alpha/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', REDOX BIOLOGY, vol. 43, http://dx.doi.org/10.1016/j.redox.2021.101993

Gao Z; Pang B; Li J; Gao N; Fan T; Li Y, 2021, 'Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis', Frontiers in Cell and Developmental Biology, vol. 9, http://dx.doi.org/10.3389/fcell.2021.679527

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?', Cancer Letters, vol. 497, pp. 100 - 111, http://dx.doi.org/10.1016/j.canlet.2020.10.016

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance', Journal of the National Cancer Center, vol. 1, pp. 75 - 87, http://dx.doi.org/10.1016/j.jncc.2021.06.001

Gao N; Li Y; Li J; Gao Z; Yang Z; Li Y; Liu H; Fan T, 2020, 'Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers', Frontiers in Oncology, vol. 10, http://dx.doi.org/10.3389/fonc.2020.598817

Dong X; Bai X; Ni J; Zhang H; Duan W; Graham P; Li Y, 2020, 'Exosomes and breast cancer drug resistance', Cell Death and Disease, vol. 11, http://dx.doi.org/10.1038/s41419-020-03189-z

Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y, 2020, 'A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications', Frontiers in Immunology, vol. 11, http://dx.doi.org/10.3389/fimmu.2020.01612

Tran PHL; Xiang D; Tran TTD; Yin W; Zhang Y; Kong L; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Duan W, 2020, 'Exosomes and Nanoengineering: A Match Made for Precision Therapeutics', Advanced Materials, vol. 32, http://dx.doi.org/10.1002/adma.201904040

Ni J; Cheung BB; Beretov J; Duan W; Bucci J; Malouf D; Graham P; Li Y, 2020, 'CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo', Experimental Cell Research, vol. 388, pp. 111850 - 111850, http://dx.doi.org/10.1016/j.yexcr.2020.111850

Tran PHL; Xiang D; Nguyen TNG; Tran TTD; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W, 2020, 'Aptamer-guided extracellular vesicle theranostics in oncology', Theranostics, vol. 10, pp. 3849 - 3866, http://dx.doi.org/10.7150/thno.39706

Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y, 2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, vol. 145, pp. 102860 - 102860, http://dx.doi.org/10.1016/j.critrevonc.2019.102860

Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, vol. 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486

Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, vol. 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106

Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y, 2019, 'Cancer stem cells in prostate cancer radioresistance', Cancer Letters, vol. 465, pp. 94 - 104, http://dx.doi.org/10.1016/j.canlet.2019.08.020

Ni J; Bucci J; Malouf D; Knox M; Graham P; Li Y, 2019, 'Exosomes in Cancer Radioresistance', Frontiers in Oncology, vol. 9, http://dx.doi.org/10.3389/fonc.2019.00869

Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y, 2019, 'Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression', BMC Cancer, vol. 19, http://dx.doi.org/10.1186/s12885-019-5824-9

Wang T; Yin W; AlShamaileh H; Zhang Y; Tran PHL; Nguyen TNG; Li Y; Chen K; Sun M; Hou Y; Zhang W; Zhao Q; Chen C; Zhang PZ; Duan W, 2019, 'A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate', Human Gene Therapy Methods, vol. 30, pp. 1 - 16, http://dx.doi.org/10.1089/hgtb.2018.237

Feng X; Bai X; Ni J; Wasinger VC; Beretov J; Zhu Y; Graham P; Li Y, 2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, vol. 9, http://dx.doi.org/10.3389/fonc.2019.00557

Ni J; Bongers A; Chamoli U; Bucci J; Graham P; Li Y, 2019, 'In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer', Cancer Control, vol. 26, pp. 1073274819846590, http://dx.doi.org/10.1177/1073274819846590

Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y, 2019, 'Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression', Theranostics, vol. 9, pp. 4130 - 4140, http://dx.doi.org/10.7150/thno.34692

Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y, 2018, 'Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo', BMC Cancer, vol. 18, pp. 1092, http://dx.doi.org/10.1186/s12885-018-5010-5

Bai X; Ni J; Beretov J; Graham P; Li Y, 2018, 'Cancer stem cell in breast cancer therapeutic resistance', Cancer Treatment Reviews, vol. 69, pp. 152 - 163, http://dx.doi.org/10.1016/j.ctrv.2018.07.004

Alshamaileh H; Wang T; Xiang D; Yin W; Tran PHL; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; Shigdar S; Duan W, 2017, 'Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-05859-z

Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y, 2017, 'Urinary biomarkers in prostate cancer detection and monitoring progression', Critical Reviews in Oncology/Hematology, vol. 118, pp. 15 - 26, http://dx.doi.org/10.1016/j.critrevonc.2017.08.002

Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y, 2017, 'Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/srep41834

Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y, 2017, 'Targeting microRNAs in prostate cancer radiotherapy', Theranostics, vol. 7, pp. 3243 - 3259, http://dx.doi.org/10.7150/thno.19934

Xiang D; Shigdar S; Bean AG; Bruce M; Yang W; Mathesh M; Wang T; Yin W; Tran PHL; Shamaileh HA; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; He A; Duan W, 2017, 'Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery', Theranostics, vol. 7, http://dx.doi.org/10.7150/thno.20168

Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y, 2016, 'Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy', Expert Review of Proteomics, vol. 13, pp. 905 - 915, http://dx.doi.org/10.1080/14789450.2016.1233065

Ni J; Cozzi P; Hung T; Hao J; Graham PH; Li Y, 2016, 'Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique', Translational Oncology, vol. 9, pp. 41 - 45, http://dx.doi.org/10.1016/j.tranon.2015.11.011

You J; Willcox M; Fitzgerald A; Schiller B; Cozzi PJ; Russell PJ; Walsh BJ; Wasinger VC; Graham PH; Li Y, 2016, 'Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling', Analytical Biochemistry, vol. 496, pp. 30 - 34, http://dx.doi.org/10.1016/j.ab.2015.12.006

Chang L; Graham P; Hao J; Ni J; Deng J; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Cancer stem cells and signaling pathways in radioresistance', Oncotarget, vol. 7, pp. 11002 - 11017, http://dx.doi.org/10.18632/oncotarget.6760

Hao J; Graham P; Chang L; Ni J; Wasinger V; Beretov J; Deng J; Duan W; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy', Oncotarget, vol. 7, pp. 74269 - 74285, http://dx.doi.org/10.18632/oncotarget.12368

Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y, 2016, 'Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer', Oncotarget, vol. 7, pp. 55771 - 55788, http://dx.doi.org/10.18632/oncotarget.9908

Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y, 2016, 'Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer', Oncotarget, vol. 7, pp. 55518 - 55528, http://dx.doi.org/10.18632/oncotarget.10833

Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y, 2015, 'Proteomics discovery of radioresistant cancer biomarkers for radiotherapy', Cancer Letters, vol. 369, pp. 289 - 297, http://dx.doi.org/10.1016/j.canlet.2015.09.013

Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y, 2015, 'Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance', Critical Reviews in Oncology/Hematology, vol. 96, pp. 507 - 517, http://dx.doi.org/10.1016/j.critrevonc.2015.07.005

Beretov J; Wasinger VC; Millar EKA; Schwartz P; Graham PH; Li Y, 2015, 'Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0141876

Xiang D; Shigdar S; Qiao G; Zhou SF; Li Y; Wei MQ; Qiao L; Al Shamaileh H; Zhu Y; Zheng C; Pu C; Duan W, 2015, 'Aptamer-mediated cancer gene therapy', Current Gene Therapy, vol. 15, pp. 109 - 119, http://dx.doi.org/10.2174/1566523214666141224095105

Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Al Shamaileh H; Yin W; Zhou SF; Zhao X; Duan W, 2015, 'Cancer stem cell targeted therapy: Progress amid controversies', Oncotarget, vol. 6, pp. 44191 - 44206, http://dx.doi.org/10.18632/oncotarget.6176


Back to profile page